Correction to: On-drug and drug-free remission by baseline symptom duration: abatacept with methotrexate in patients with early rheumatoid arthritis (Rheumatology International, (2018), 38, 12, (2225-2231), 10.1007/s00296-018-4173-3) Article uri icon

Overview

MeSH Major

  • Antirheumatic Agents
  • Arthritis, Rheumatoid
  • C-Reactive Protein
  • Disease Progression
  • Rheumatoid Factor
  • Tumor Necrosis Factor-alpha

abstract

  • © 2018, The Author(s). The article “On-drug and drug-free remission by baseline symptom duration: abatacept with methotrexate in patients with early rheumatoid arthritis”, written by Vivian P.Bykerk, was originally published Online First without open access. After publication in volume [38], issue [12], page [2225–2231] the author decided to opt for Open Choice and to make the article an open access publication. Therefore, the copyright of the article has been changed to © The Author(s) 2018 and the article is forthwith distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creat iveco mmons .org/licen ses/ by/4.0/), which permits use, duplication, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made. The original article has been corrected.

publication date

  • January 2019

Research

keywords

  • Article

Identity

Digital Object Identifier (DOI)

  • 10.1007/s00296-018-4232-9